Answers are grounded in this paper and cite their sources.
Surveillance shows increasing antimicrobial resistance in Neisseria gonorrhoeae, highlighting the need for genomic monitoring.
Surveillance of antimicrobial resistance in Neisseria gonorrhoeae was conducted in France from 2018 to 2023. The proportion of isolates with cefixime MIC ≥ 0.032 mg/L increased from 8.1% in 2018–2022 to 23.5% in 2023. This sharp rise was driven by the expansion of two clones, ST1580 and ST16676, carrying the mosaic penA-34.001 and penA-34.007 alleles, respectively. These findings highlight the essential role of genomic surveillance in monitoring the evolution of resistance determinants in N. gonorrhoeae .
No takes yet. Share an insight, caveat, or question.
Caméléna et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: